Clinical Trials : Migraine without Aura

Not yet recruiting

Study Name: Efficacy Study of Acupuncture in the Prevention of Migraine Without Aura
Condition: Migraine Without Aura
Date: 2016-04-10
Interventions:

Device: Verum acupuncture The

Completed

Study Name: Dysport® In Migraine Without Aura Prophylaxis : DIMWAP Study
Condition: Migraine Without Aura Prophylaxis
Date: 2005-11-23
Interventions: Drug: Botulinum Toxin type A (Dysport ® ) IM/SC 6-sites pericranial injection

Completed

Study Name: Functional MRI (fMRI) in CGRP Induced Migraine
Condition: Migraine Without Aura
Date: 2006-08-11
Interventions: Drug: infusion of calcitonin gene related peptide (CGRP)

Recruiting

Study Name: Investigation of Serotonin Receptor Binding in the Migraine Brain Using Positron Emission Tomography
Condition: Migraine Without Aura
Date: 2014-12-02
Interventions: Other: PET scan with two different 5-HT receptor ligands

Completed

Study Name: PACAP Induced Migraine Attacks in Patients With High and Low Genetic Load
Condition: Migraine Without Aura
Date: 2014-06-05
Interventions: Drug: PACAP Pituitary adenylate cyclase-activating polypeptide (PACAP)

Completed

Study Name: CGRP Induced Migraine Attacks in Patients With High and Low Genetic Load
Condition: Migraine Without Aura
Date: 2013-08-10
Interventions: Drug: CGRP Calcitonin-gene-related-peptide (CGRP) Ot

Completed

Study Name: Effect of PACAP38/VIP on Migraineurs Measured by Magnetic Resonance
Condition: Migraine Without Aura
Date: 2011-11-09
Interventions:

Drug: Pituitary Adenylate Cyclase-Activating Polypeptide-38

Completed

Study Name: The Effect of Histamine H1 Receptor Antagonist, Clemastin, on PACAP38 Induced Headache in Migraine Patients
Condition: Migraine Without Aura
Date: 2014-10-07
Interventions: Drug: PACAP38 Giving doses of 4, 6 or 8 pg/kg/min on three separate trial days.

Completed

Study Name: Study of the Safety and Effectiveness of NXN-188 for the Treatment of Migraine Headache Without Aura
Condition: Migraine Without Aura
Date: 2009-08-14
Interventions:

Drug: NXN-188 200 mg capsules,

Completed

Study Name: PACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood Flow
Condition: Migraine Without Aura
Date: 2006-09-21
Interventions: Drug: PACAP38 10 pmol/kg/min given one time

Search for Clinical Trial Results

Migraine without Aura - 17 Studies Found

Status	Study
Not yet recruiting	Study Name: Efficacy Study of Acupuncture in the Prevention of Migraine Without Aura Condition: Migraine Without Aura Date: 2016-04-10 Interventions: Device: Verum acupuncture The
Completed	Study Name: Dysport® In Migraine Without Aura Prophylaxis : DIMWAP Study Condition: Migraine Without Aura Prophylaxis Date: 2005-11-23 Interventions: Drug: Botulinum Toxin type A (Dysport ® ) IM/SC 6-sites pericranial injection
Completed	Study Name: Functional MRI (fMRI) in CGRP Induced Migraine Condition: Migraine Without Aura Date: 2006-08-11 Interventions: Drug: infusion of calcitonin gene related peptide (CGRP)
Recruiting	Study Name: Investigation of Serotonin Receptor Binding in the Migraine Brain Using Positron Emission Tomography Condition: Migraine Without Aura Date: 2014-12-02 Interventions: Other: PET scan with two different 5-HT receptor ligands
Completed	Study Name: PACAP Induced Migraine Attacks in Patients With High and Low Genetic Load Condition: Migraine Without Aura Date: 2014-06-05 Interventions: Drug: PACAP Pituitary adenylate cyclase-activating polypeptide (PACAP)
Completed	Study Name: CGRP Induced Migraine Attacks in Patients With High and Low Genetic Load Condition: Migraine Without Aura Date: 2013-08-10 Interventions: Drug: CGRP Calcitonin-gene-related-peptide (CGRP) Ot
Completed	Study Name: Effect of PACAP38/VIP on Migraineurs Measured by Magnetic Resonance Condition: Migraine Without Aura Date: 2011-11-09 Interventions: Drug: Pituitary Adenylate Cyclase-Activating Polypeptide-38
Completed	Study Name: The Effect of Histamine H1 Receptor Antagonist, Clemastin, on PACAP38 Induced Headache in Migraine Patients Condition: Migraine Without Aura Date: 2014-10-07 Interventions: Drug: PACAP38 Giving doses of 4, 6 or 8 pg/kg/min on three separate trial days.
Completed	Study Name: Study of the Safety and Effectiveness of NXN-188 for the Treatment of Migraine Headache Without Aura Condition: Migraine Without Aura Date: 2009-08-14 Interventions: Drug: NXN-188 200 mg capsules,
Completed	Study Name: PACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood Flow Condition: Migraine Without Aura Date: 2006-09-21 Interventions: Drug: PACAP38 10 pmol/kg/min given one time